Endpoints News – Biotech and pharma business news, with a focus …
Endpoints News provides up-to-date biotech, drug, pharma, and health news for business and professional readers.
News – Endpoints News
Viking CEO on ‘shocking’ market reaction to oral obesity data, preparing for Phase 3. 17 hours ago. R&D. Manufacturing.
Big dreams dominate among next-gen biotech players
Sep 22, 2024 · Here’s John Carroll’s top picks for the next-gen players of 2022 most likely to make their mark — or go down fighting for a landmark change. This marks Carroll’s 20th year selecting top private biotechs for special recognition. Join us at this special event in Boston to recognize this year’s group. sponsored by. see the winners.
About Endpoints News – Endpoints News
John D. Carroll is a biotech analyst and writer with decades of prize-winning experience in journalism. A co-founder of Endpoints News, he has covered biopharma for the past 20 years. Aside from ...
Endpoints at #JPM22 - A look at what's to come in 2022
Endpoints has been there to chronicle it with wall-to-wall coverage, and our founder and editor John Carroll has convened top newsmakers to provide detailed insights about their strategies. For #JPM22, Endpoints is expanding on our proud tradition with multiple panels addressing the most important issues in biopharma R&D. title sponsor.
ESMO23 | Cancer breakthroughs and barriers in oncology R&D
After a decade of patient breakthroughs leveraging technologies like immunotherapy, ADCs and targeted therapies, cancer R&D is staring down its next era. Our expert panel will look at how the R&D landscape has shifted, new attempts to go after cancer's “undruggable” targets and how the field is thinking about where the goalposts are in what ...
It’s mission critical this time as biotech looks to bounce back
Now it’s time to fix that. Getting together, exploring new deals, hoping someone uncorks a whopper of a buyout, all while assessing the year ahead — these are all annual traditions set to make a comeback at the start of 2023. And this year Endpoints News will be at the heart of it all, offering a hybrid slate of events that will be both ...
Subscribe - Endpoints News
Endpoints Weekly Recaps the most important developments Saturday at 6 AM ET (sample issue) Post-Hoc Analysis and insight from the newsroom, plus dispatches from medical meetings and conferences 1 ...
'Moonshot' at liver cell therapy biotech Ambys Medicines comes …
Feb 1, 2023 · Evommune raises $115M for I&I pipeline and prepares for Phase 2 results October 31, 2024. Ambys Medicines, backed by Third Rock Ventures and a partner to Takeda, closed its doors in recent ...
Agenda: Endpoints at #JPM24
Top predictions for biotech in 2024. Catalent CEO Alessandro Maselli will be back at the big JPM healthcare confab to talk with Endpoints News founder John Carroll about their top predictions of what’s coming up for the biotech industry in 2024. The stakes couldn’t be higher as the industry grapples with headwinds and new opportunities in a ...